| SIIEX | VDVIX | SIIEX / VDVIX | |
| Total Expense Ratio | 0.89 | 0.16 | 556% |
| Annual Report Gross Expense Ratio | 1.28 | 0.16 | 800% |
| Fund Existence | 19 years | 13 years | - |
| Gain YTD | 26.036 | 16.722 | 156% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 216M | 324B | 0% |
| Annual Yield % from dividends | 2.72 | 2.37 | 115% |
| Returns for 1 year | 33.48 | 21.95 | 153% |
| Returns for 3 years | 85.05 | 63.48 | 134% |
| Returns for 5 years | 49.80 | 41.64 | 120% |
| Returns for 10 years | 78.42 | 110.42 | 71% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GMXRX | 16.31 | 0.14 | +0.87% |
| Nationwide Mid Cap Market Idx R | |||
| VGSNX | 20.80 | 0.16 | +0.78% |
| Vanguard Real Estate Index Institutional | |||
| AVEEX | 18.17 | 0.12 | +0.66% |
| Avantis® Emerging Markets Equity Instl | |||
| FRVFX | 52.91 | 0.25 | +0.47% |
| Franklin Small Cap Value C | |||
| RYCFX | 53.22 | 0.09 | +0.17% |
| Rydex Biotechnology C | |||